Page last updated: 2024-08-24

dexmedetomidine and Diabetes Mellitus

dexmedetomidine has been researched along with Diabetes Mellitus in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's7 (100.00)2.80

Authors

AuthorsStudies
Harbell, MW; Kraus, MB; Reynolds, EG; Sharpe, EE; Van Decar, LM1
Gallo de Moraes, A; Harbell, MW; Kosiorek, H; Kraus, MB; Leuzinger, K; Quillen, J; Reynolds, E; Sharpe, EE; Smith, J1
He, Y; Li, C; Lin, Y; Wei, Y; Yao, G; Yu, H; Zhang, W; Zhang, Y1
Hu, Z; Huang, Y; Li, F; Zhan, H1
Fan, ZW; Li, K; Pan, T; Tang, YX; Wang, DJ; Yan, DL; Zhang, H; Zhang, HT1
Hasoon, J; Markan, S; Nguyen, A; Tang, T; Wagle, R1
Li, CJ; Mu, DL; Wang, BJ; Wang, DX1

Reviews

1 review(s) available for dexmedetomidine and Diabetes Mellitus

ArticleYear
Diabetes insipidus related to sedation in the intensive care unit: A review of the literature.
    Journal of critical care, 2023, Volume: 75

    Topics: Dexmedetomidine; Diabetes Insipidus; Diabetes Mellitus; Humans; Hypnotics and Sedatives; Intensive Care Units; Ketamine; Polyuria; Sevoflurane

2023

Trials

1 trial(s) available for dexmedetomidine and Diabetes Mellitus

ArticleYear
The effect of dexmedetomidine on intraoperative blood glucose homeostasis: secondary analysis of a randomized controlled trial.
    BMC anesthesiology, 2021, 05-07, Volume: 21, Issue:1

    Topics: Aged; Analgesics, Non-Narcotic; Blood Glucose; Dexmedetomidine; Diabetes Mellitus; Female; Homeostasis; Humans; Hyperglycemia; Male; Monitoring, Intraoperative; Operative Time; Risk Factors

2021

Other Studies

5 other study(ies) available for dexmedetomidine and Diabetes Mellitus

ArticleYear
Dexmedetomidine-associated diabetes insipidus during skull base surgery in a pediatric patient.
    Paediatric anaesthesia, 2023, Volume: 33, Issue:3

    Topics: Adolescent; Adult; Child; Dexmedetomidine; Diabetes Insipidus; Diabetes Mellitus; Humans; Male; Polyuria; Skull Base

2023
Dexmedetomidine alleviates oxidative stress and mitochondrial dysfunction in diabetic peripheral neuropathy via the microRNA-34a/SIRT2/S1PR1 axis.
    International immunopharmacology, 2023, Volume: 117

    Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Apoptosis; Dexmedetomidine; Diabetes Mellitus; Diabetic Neuropathies; MicroRNAs; Mitochondria; Oxidative Stress; Rats; Sirtuin 2; Sphingosine-1-Phosphate Receptors

2023
Dexmedetomidine ameliorates diabetic cardiomyopathy by inhibiting ferroptosis through the Nrf2/GPX4 pathway.
    Journal of cardiothoracic surgery, 2023, Jul-10, Volume: 18, Issue:1

    Topics: bcl-2-Associated X Protein; Dexmedetomidine; Diabetes Mellitus; Diabetic Cardiomyopathies; Ferroptosis; Humans; Mannitol; NF-E2-Related Factor 2; Reactive Oxygen Species; Superoxide Dismutase

2023
Dexmedetomidine as an anesthetic adjunct is associated with reduced complications and cardiac intensive care unit length of stay after heart valve surgery.
    BMC anesthesiology, 2023, 08-05, Volume: 23, Issue:1

    Topics: Cardiac Surgical Procedures; Dexmedetomidine; Diabetes Mellitus; Heart Valves; Humans; Intensive Care Units; Length of Stay; Postoperative Complications; Retrospective Studies; Risk Factors

2023
Dexmedetomidine-induced diabetes insipidus during coronary artery bypass graft surgery.
    Anaesthesiology intensive therapy, 2023, Volume: 55, Issue:3

    Topics: Coronary Artery Bypass; Dexmedetomidine; Diabetes Mellitus; Humans

2023